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Sentinel lymph node status provides important information in
patients with tumours that metastasise to superficial lymph nodes,
such as melanoma, breast cancer or vulvar cancer (Morton et al,
1992; Giuliano et al, 1994; Levenback et al, 1994). The sentinel
lymph node (SLN) is defined as the first draining lymph node of
an anatomical region, and the histological examination of the
sentinel lymph node would be representative for the non-sentinel
lymph nodes. A histologically negative sentinel lymph node
would predict the absence of tumour metastases in the other
non-sentinel lymph nodes (Morton et al, 1992). The methods
to identify such nodes are staining with isosulfan blue dye
(Lymphhazurin 1%, Ben Venue Labs, Inc, Richmond, VA) or by
detection of the lymph node uptake of a radionuclide that spreads
the same way as lymphatics. Detection of SLN has nearly become
a standard technique for determining the nodal status in patients
with cutaneous melanoma (Statius Muller et al, 1999). The
successful identification of the sentinel lymph node by a gamma
camera is only the first step, because it is necessary to examine the
sentinel nodes histopathologically and immunohistochemically for
accurate identification of even microscopic metastasis. 
In superficial tumours, such as melanomas or breast cancer,
SLN detection can prevent unnecessary extensive lymph node
resections. Radical hysterectomy with pelvic lymphadenectomy is
the most commonly performed definitive surgical procedure for
patients with Figo IB cervical cancer. Few of these patients do
have pelvic lymph node metastasis (Delgado et al, 1989; Magrinal
et al, 1999), but many patients with radical lymph node resection
suffer from side effects after surgery. Therefore some investigators
recommended a less radical approach for early cervical cancer
with precise preoperative determination of lymph node metastases
(Kinney et al, 1995; Shingleton, 1998; Magrina et al, 1999). In
spite of computed tomography and magnetic resonance imaging in
clinical staging of cervical cancer patients accuracy of preopera-
tive lymph node status is rather poor (Scheidler et al, 1997). 
Therefore the aim of the present study was to examine the feasi-
bility and validity of sentinel lymph node detection in patients
with early cervical cancer to possibly reduce morbidity following
possibly unnecessary radical lymph node resection. 
PATIENTS AND METHODS 
Between January 1999 and September 2000 all patients with histo-
logically proven early cervical cancer who were referred to our
department for radical hysterectomy, were asked to participate in
this study, approved by the local ethics committee. Patients with
prior chemotherapy, pelvic radiotherapy or prior retroperitoneal
surgery were excluded. Finally 14 patients with cervical cancer
stage IBI were eligible for this study and signed written informed
consent. Patients age ranged from 28 to 67 years (mean 46 years).
All patients underwent preoperative CT and MRI scan. Clinical
patient and tumour characteristics are shown in Table 1. 
On the day before surgery we intradermally injected one depot
of 99m-Tc-labelled human colloid (Albu-res®; Pharmaceutical
Nycomed Amersham, Braunschweig, Germany) in each quadrant
of the cervix. The colloid was filtered to a range from 200–450 nm
to obtain the small particle fraction. The dose ranged from 60–111
MBq. For application we used a 27 gauge hypodermic needle.
After injection, dynamic lymphoscintigraphy (28 images, 60
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64 × 64 or as high as available) was done using a single- or double-
headed gamma camera in patients supine position from an anterior
view. Additional static images (1 image per 5 minutes) from ante-
rior and lateral views were taken after the dynamic study and
about 2 hours after injection. The localization of the sentinel node
was marked on the skin to guide the surgeon. 
At the time of surgery first the hot nodes were detected before
and after opening the retroperitoneal spaces of the pelvic side wall
using a hand-held collimated gamma probe (ScintiProbe MR-100,
pol.hi.tech, Carsoli, C11 probe, Italy). The count rate in vivo and
in vitro was determined. The localization and the count rate of all
suspected sentinel nodes in relation to the major pelvic vessels
were documented exactly. After separate removal of the radioac-
tive nodes, the complete nodal tissue along the obturator nerve and
the iliacal vessels was removed bilaterally up to the level of the
aortic bifurcation. Finally, the pelvis was re-examined with the
gamma probe to detect residual radioactivity. After sentinel node
procedure radical hysterectomy was completed. 
Routine histopathological examination of the sentinel and of
all other lymph nodes was performed using haematoxylin-eosin
staining and serial sections with standard techniques. In case of
negative sentinel nodes additional immunohistochemical exami-
nation was performed. Findings at surgery were correlated with
final pathology reports. 
RESULTS 
All 14 patients underwent transperitoneal lymph-node resection at
the planned radical hysterectomy. Lymphoscintigraphy showed
focal uptake of technetium99 in 13 of 14 patients (Figure 1). Only
in 1 woman neither lymphoscintigraphy on the day before surgery
nor intraoperative gamma probe detection demonstrated focal
uptake of technetium99. This was due to incorrect subdermal injec-
tion and spillage of the tracer, therefore no SLN was identified.
Our results are shown in Table 2. We could detect 26 sentinel
nodes by handheld gamma probe during surgery. In 8 of 13
patients, one or more unilateral sentinel nodes were identified
intraoperatively by the gamma probe, in 5 women we found SLNs
bilaterally. The location of SLNs was variable and differed from
the external iliac, internal iliac, parametrial and obturator lymph
node chains. 25 histologically negative SLNs were retrieved from
lymph node chains in which nodal disease was absent in final
histology and immunohistochemistry. We found histopathologi-
cally positive sentinel lymph nodes in only 1 patient and immuno-
histochemical examination demonstrated positive results, too. In
this case we even found 2 sentinel nodes. The first sentinel node
was located in the left parametrium, the second was located at the
right external iliac area and both nodes were the only histopatho-
logically positive nodes, accurately representing the real nodal
status. 
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Table 1 Patients characteristics 
N (Stage IBI) 14 
Age 28–67 
Tumour size (cm) 1.6–3.8 
Histology
SCC 12 
Adenocarcinoma 2 
Grading
I5  
II 9 
III 0 
right left
SLN
covered injection site
marker image
0 cm
5 cm
10 cm
umbilicus
Figure 1 Lymphoscintigraphy in cervical cancer 
Table 2 Sentinel Lymph Node Pathology 
Sentinel node detection 13/14 patients 
Number of SLN 26 LN 
Localization of SLN 
External iliac 17 LN 
Internal iliac 5 LN 
Obturator nerve 3 LN 
Parametrium 1 LN 
Pathology of SLN 
Standard staining (H&E) 2 LN (1 patient) 
Immunohistochemistry 2 LN (1 patient) 
Other LN 0 LN 
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The validation of the sentinel node procedure as it was introduced
in 1977 by Cabanas has led to the rediscovery of lymphoscintig-
raphy (Cabanas, 1977). The combination of preoperative
lymphatic mapping with intraoperative probe detection is increas-
ingly used to identify the sentinel node in melanoma, breast
cancer, and in other malignancies such as penile and vulvar cancer.
Different studies showed that the sentinel node detection is a
highly accurate diagnostic procedure (Giuliano et al, 1994;
DeHullu et al, 1998; Gershenwald et al, 1999; DeHullu et al,
2000). In contrary to superficial carcinoma the physiology of
lymphatic drainage from the cervix is not yet well established. A
technique based on the SLN procedure that makes mapping of the
regional lymphatics possible and feasible may be appropriate in
this patient collective. In the past there was no evidence for
sentinel node stations in cervical cancer. Benedetti-Panici et al
examined lymphatic spread through paracervical tissue but found
metastases in that area in only 29% (Benedetti-Panici et al, 1996).
In cases of lymph node metastases the superficial obturator area
was affected most commonly (86%). As a matter of fact radical
lymph node dissection during surgery in early stage cervical
cancer is discussed controversially (Kinney et al, 1995;
Shingleton, 1998; Magrina et al, 1999). For instance, cervical
tumour size less than 2 cm has been associated with nodal metas-
tases in only 0–16% of cases (Delgado et al, 1989; Magrina et al,
1999). Recently some authors described the sentinel node proce-
dure in cervical cancer by blue dye uptake (Echt et al, 1999;
Dargent et al, 2000; Medl et al, 2000; O’Boyle et al, 2000) or by
lymphoscintigraphy (Kamprath et al, 2000), whereas some authors
used both techniques to detect SLNs in cervical cancer. Verheijen
et al found in a series of 10 patients that the typical location of
sentinel nodes was the external iliac area (6 of 18 sentinel nodes)
and the chain of the obturator nodes (Verheijen et al, 2000).
Verheijen et al also showed that visual detection of dye uptake in
lymph nodes is difficult and sometimes unreliable especially in the
parametrial nodes. In his study, blue staining was seen in only 4 of
10 women and did not identify any sentinel nodes additionally to
those detected by the gamma probe. Echt et al reported a SLN-
detection rate for cervical cancer of 15.4% using blue dye (Echt
et al, 1999). O’Boyle et al reported a detection rate of 60% in his
series of 20 patients using isosulfan blue dye (O’Boyle et al,
2000). Medl et al reported that he found in all 3 cases 2 to 3 blue-
stained (sentinel) lymph nodes located either at the external iliac or
in the obturator chain. The blue coloured nodes were histopatho-
logical positive, whereas all other pelvic lymph nodes removed
were negative (Medl et al, 2000). Kamprath et al investigated the
validity of laparoscopic SLN detection using lymphoscintigraphy.
They detected sentinel nodes in 16 of 18 patients (Kamprath et al,
2000). Dargent et al reported a failure rate between 10% and 50%,
depending on the amount of blue dye injected peritumourally
(Dargent et al, 2000). 
In our present study we evaluated the combination of preopera-
tive lymphatic mapping with intraoperative probe detection in IBI
cervical cancer patients. According to the published literature we
could show that most SLNs were found in the external iliac and
obturator area. 
In case of negative sentinel node, we did not find any other
histopathologically positive lymph node. According to our results,
the necessity of sentinel lymphonodectomy in patients with nega-
tive SLNs has to be questioned. However randomised trials are
needed for assessing accuracy of this technique. In patients with
positive SLNs full lymphonodectomy still is mandatory. 
Detection rate compared with previous data in the literature is
shown in Table 3. In comparison with the visual detection rates in
those studies using blue dye our detection rate and the detection
rate in those studies using lymphoscintigraphy was good. If the
sentinel node procedure in cervical cancer proves to detect all
microscopically involved nodes, treatment of women suffering
from cervical cancer could be modified to less, or if necessary to
even more radical, treatment. In patients with Figo IB cervical
cancer complete lymphonodectomy might be omitted if the
sentinel lymph node is negative. Although sentinel node detection
by lymphoscintigraphy requires special equipment and is rather
expensive it could help us to save money and time in the operating
theatre. 
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